2 months ago
AXGN
AnalystsConstantine DavidesConstantine Davides's Stock Forecasts
AnalystsConstantine Davides
Analyst Ranking
Bottom 1%
#4838 out of 4868 analysts
Average Return
-25.36%
Win Rate
33%31 out of 95
Risk vs Reward
Poor
Good
Constantine Davides's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biovie IncBIVI | +217.17% | $33.20 | $105.30 | 2022-03-17 - 2023-03-16 | Strong Buy |
Optimizerx CorpOPRX | +124.63% | $4.06 | $9.12 | 2024-11-14 - 2025-04-30 | Buy |
Nanoviricides IncNNVC | +83.91% | $1.31 | $2.40 | 2023-06-01 - 2024-05-31 | Strong Buy |
Optimizerx CorpOPRX | +65.52% | $5.51 | $9.12 | 2025-02-06 - 2025-04-30 | Buy |
Electromed IncELMD | +44.87% | $11.88 | $17.21 | 2023-05-11 - 2024-05-10 | Strong Buy |
Constantine Davides Analyst Color
Get additional color on Constantine Davides's coverage of popular stocks
Constantine Davides's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Privia Health Group IncPRVA | 4 | Buy | $29.00 | +23.51% | Reiterates | 3 days ago |
Evolent Health IncEVH | 7 | Buy | $13.00 | +31.85% | Reiterates | 3 days ago |
U S Physical Therapy IncUSPH | 2 | Buy | $113.00 | +58.91% | Reiterates | 9 days ago |
Option Care Health IncOPCH | 4 | Buy | $36.00 | +11.42% | Reiterates | 9 days ago |
Addus Homecare CorpADUS | 2 | Buy | $150.00 | +43.47% | Maintains | 21 days ago |
Axogen IncAXGN | 1 | Buy | $26.00 | +59.80% | Maintains | 2 months ago |
American Tower CorpAMT | 1 | Buy | $248.00 | +10.02% | Maintains | 2 months ago |
Amn Healthcare Services IncAMN | 9 | Buy | $33.00 | +61.53% | Maintains | 2 months ago |
Optimizerx CorpOPRX | 7 | Buy | $8.00 | -12.28% | Reiterates | 3 months ago |
Healthequity IncHQY | 4 | Buy | $107.00 | +24.83% | Maintains | 5 months ago |
Progyny IncPGNY | 2 | Buy | $31.00 | +35.73% | Maintains | 9 months ago |
Agilon Health IncAGL | 1 | Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Nemaura Medical IncNMRD | 4 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Nanoviricides IncNNVC | 3 | Strong Buy | $5.25 | N/A | Assumes | 2 years ago |
Scienture Holdings IncSCNX | 2 | Strong Buy | $18.75 | N/A | Maintains | 2 years ago |
Longeveron IncLGVN | 5 | Strong Buy | $125.00 | N/A | Reiterates | 2 years ago |
Electromed IncELMD | 3 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
Innoviva IncINVA | 4 | Strong Buy | $22.50 | N/A | Reiterates | 2 years ago |
Carecloud IncCCLD | 2 | Strong Buy | $8.50 | N/A | Reiterates | 2 years ago |
Hoth Therapeutics IncHOTH | 4 | Strong Buy | $14.00 | N/A | Reiterates | 2 years ago |
Hcw Biologics IncHCWB | 4 | Strong Buy | $360.00 | N/A | Reiterates | 2 years ago |
Bone Biologics CorpBBLG | 3 | Strong Buy | $540.00 | N/A | Reiterates | 2 years ago |
Pasithea Therapeutics CorpKTTA | 2 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Acer Therapeutics IncACER | 2 | Strong Buy | $7.00 | N/A | Reiterates | 2 years ago |
Volitionrx LtdVNRX | 2 | Strong Buy | $6.00 | N/A | Reiterates | 2 years ago |
Grace Therapeutics IncGRCE | 2 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
Biovie IncBIVI | 2 | Strong Buy | $80.00 | N/A | Maintains | 3 years ago |
Healthcare Triangle IncHCTI | 2 | Strong Buy | $20.00 | N/A | Maintains | 3 years ago |
Ispecimen IncISPC | 2 | Strong Buy | $85.00 | N/A | Maintains | 3 years ago |
Invacare CorpIVCRQ | 1 | Strong Buy | $2.75 | N/A | Initiates Coverage On | 3 years ago |
Tc Biopharm PLCTCBP | 1 | Strong Buy | $8,000,000.00 | N/A | Initiates Coverage On | 3 years ago |
G Medical Innovations Holdings LtdGMVDF | 1 | Strong Buy | $210.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.